Stockscreener 앱 받기
3.52
21.56%
-0.98
Neuronetics Inc 주식(STIM)의 최신 뉴스
Neuronetics Q1 2025 slides: Combined entity targets profitability by Q3 amid 84% revenue growth - Investing.com Canada
Neuronetics: Q1 Earnings Snapshot - MySA
Neuronetics (STIM) Surpasses Q1 Revenue Expectations with $32M | - GuruFocus
Neuronetics Reports First Quarter 2025 Financial and Operating R - GuruFocus
Neuronetics Inc (STIM) Q1 2025 Earnings: Revenue Surpasses Estimates at $32.0M, EPS Misses at $(0.21) - GuruFocus
Neuronetics reports inducement grant - Medical Buyer
Neuronetics Announces CFO Retirement Amidst Q1 Growth - TipRanks
Neuronetics, Inc. SEC 10-Q Report - TradingView
Neuronetics Reports First Quarter 2025 Financial and Operating Results - ADVFN
Renaissance Technologies LLC Has $255,000 Position in Neuronetics, Inc. (NASDAQ:STIM) - Defense World
JPMorgan Chase & Co. Increases Stock Holdings in Neuronetics, Inc. (NASDAQ:STIM) - Defense World
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | STIM Stock News - GuruFocus
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Neuronetics Expands Team with 4,500 Share RSU Package for Three New Strategic Hires - Stock Titan
Transcranial Magnetic Stimulator Market Generated - openPR.com
Neuronetics, Inc.'s (NASDAQ:STIM) 30% Jump Shows Its Popularity With Investors - simplywall.st
Neuronetics Announced as a Winner by 2022 Merit Awards for HealthCare in the Patient Care Category - IT Business Net
Geode Capital Management LLC Buys 8,466 Shares of Neuronetics, Inc. (NASDAQ:STIM) - Defense World
Taking the lead: Neuronetics Inc (STIM) - Sete News
Insider’s View: Deciphering Neuronetics Inc (STIM)’s Financial Health Through Ratios - DWinneX
Neuronetics Inc (STIM) stock on the rise: An overview - uspostnews.com
Why Neuronetics, Inc. (STIM) is Surging in 2025 - Insider Monkey
Transneural Therapeutics Appoints CNS Drug Development Expert, Mark A. Demitrack, MD, as Chief Research and Development Officer - The Malaysian Reserve
Neuronetics, Inc.'s (NASDAQ:STIM) market cap surged US$39m last week, individual investors who have a lot riding on the company were rewarded - simplywall.st
Neuronetics to Announce Q1 2025 Results and Host Live Conference Call on May 6 - MSN
Was there any good news for Neuronetics Inc (STIM) stock in the last session? - uspostnews.com
Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call | STIM Stock News - GuruFocus
Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call - The Manila Times
Medical Tech Leader Neuronetics Sets Q1 2025 Earnings Release: Key Details for Neurohealth Investors - Stock Titan
Neuronetics, Inc. (NASDAQ:STIM) Short Interest Update - Defense World
Neuronetics Reports 2024 Financial Results and Strategic Advances - MSN
Transcranial Magnetic Stimulator Market to Witness Remarkable - openPR.com
Neuronetics Announces Expanded Coverage for NeuroStar TMS to Treat Adolescent Depression - MSN
Even though Neuronetics (NASDAQ:STIM) has lost US$30m market cap in last 7 days, shareholders are still up 130% over 5 years - simplywall.st
Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression - The Manila Times
Major Insurance Breakthrough: NeuroStar's Teen Depression Treatment Now Covered for 15 Million Lives - Stock Titan
Neuronetics Revises Financial Results for Q4 and Full Year 2024 - MSN
Neuronetics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs (NASDAQ:STIM) - Seeking Alpha
Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results - The Manila Times
Neuronetics Some Non-Cash Revisions Made To Financial Statements Related To Co's Acquisition Of Greenbrook Tms & Shares Outstanding In Q4 - Marketscreener.com
Neuronetics Updates Financial Results: Q4 Losses Deepen After Greenbrook Deal Review - Stock Titan
Transcranial Magnetic Stimulator Market Is Booming So Rapidly - openPR.com
This Penny Stock Is Up 170% in 2025 and Analysts Think It Can Rally Further From Here - The Globe and Mail
FDA Clears NeuroStar's TMS Therapy for Adolescents with Major Depressive Disorder - MSN
While private equity firms own 38% of Neuronetics, Inc. (NASDAQ:STIM), retail investors are its largest shareholders with 43% ownership - Yahoo
Wall Street Analysts Think Neuronetics (STIM) Could Surge 34.98%: Read This Before Placing a Bet - Yahoo Finance
Neuronetics Inc (STIM) Q4 2024 Earnings Report Preview: What To Look For - GuruFocus.com
Transcranial Magnetic Stimulator Market Positioned - openPR
Neuronetics’ SWOT analysis: merger synergies boost growth prospects for stock - Investing.com India
Earnings call transcript: Neuronetics Q4 2024 sees revenue growth, stock rises - Investing.com Australia
Neuronetics, Inc. to Host Earnings Call - ACCESS Newswire
0.01%
4.21%
자본화:
|
볼륨(24시간):